Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-MAP + GM-CSF + RT + Surgery for Soft Tissue Sarcoma
NCT00652860Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2001
- Primary completion
- Nov 2006
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of sargramostim in soft tissue sarcoma (STS), sponsored by Mayo Clinic. Started Aug 2001; status: completed.
02
Drugs
sargramostim
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00652860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652860.